Subacute stent thrombosis with spontaneously resolved secondary thrombi in paroxysmal nocturnal hemoglobinuria: a case report

BMC Cardiovasc Disord. 2022 Sep 12;22(1):408. doi: 10.1186/s12872-022-02850-z.

Abstract

Background: Stent thrombosis (ST) is a serious complication; however, a method to prevent ST in patients with thrombophilic diseases has not been established.

Case presentation: We report a case of subacute ST in a patient with paroxysmal nocturnal hemoglobinuria (PNH) who was receiving continuous heparin treatment in addition to the usual dual antiplatelet therapy for contrast defects at the proximal site of the occluded right coronary artery and the proximal site of the left circumflex artery. Despite the resolution of thrombi in secondary lesions, subacute ST occurred. After percutaneous coronary intervention for ST, triple therapy, including oral anticoagulation for PNH-related thrombosis, was initiated. The patient subsequently underwent craniotomy hematoma removal for hemorrhagic cerebral infarction.

Conclusions: Reported cases of ST in patients with PNH are very few, and this case adds evidence with respect to antithrombotic therapy in patients with thrombotic tendencies. Both thrombosis and bleeding should be considered when administering antithrombotic therapy to patients with thrombotic diseases. If there are specific treatments for thrombophilic diseases, they should be initiated early.

Keywords: Antithrombotic therapy; Case report; Paroxysmal nocturnal hemoglobinuria; Percutaneous coronary intervention; Stent thrombosis.

Publication types

  • Case Reports

MeSH terms

  • Fibrinolytic Agents
  • Hemoglobinuria, Paroxysmal* / complications
  • Hemoglobinuria, Paroxysmal* / diagnosis
  • Hemoglobinuria, Paroxysmal* / therapy
  • Heparin
  • Humans
  • Stents
  • Thrombophilia*
  • Thrombosis* / diagnostic imaging
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology

Substances

  • Fibrinolytic Agents
  • Heparin